Literature DB >> 9218750

Comparison of IA-2 with IA-2beta and with six other members of the protein tyrosine phosphatase family: recognition of antigenic determinants by IDDM sera.

A L Notkins1, B Zhang, Y Matsumoto, M S Lan.   

Abstract

To study the expression of protein tyrosine phosphatases (PTPs) in pancreatic islets, a cDNA library from islet cells was constructed and analysed. Twenty-one different PTPs were found to be expressed in islet cells, including three previously unknown PTPs. One of these, IA-2beta, was cloned, sequenced, and found to be related to IA-2, a major autoantigen in insulin-dependent diabetes mellitus (IDDM). The intracellular and extracellular domains of IA-2beta were 74 and 27% identical, respectively, to the intracellular and extracellular domains of IA-2. Approximately 70 and 45% of sera from patients with IDDM had autoantibodies that immunoprecipitated recombinant IA-2 and IA-2beta, respectively. By use of deletion mutants, we were able to show that the autoantibodies reacted with the intracellular, and not the extracellular, domains of IA-2 and IA-2beta, and that the major antigenic determinants resided within the COOH-terminus of the intracellular domains. Further studies revealed that approximately 97% of the IDDM sera that reacted with IA-2beta also reacted with IA-2, whereas only 50% of IDDM sera that reacted with IA-2 also reacted with IA-2beta. In contrast to the reactivity of IDDM sera with the IA-2 and IA-2beta, IDDM sera did not react with six other members of the PTP family. It is concluded that many members of the PTP family are expressed in pancreatic islets, but thus far only IA-2 and IA-2beta appear to be recognized as autoantigens by IDDM sera.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9218750     DOI: 10.1006/jaut.1997.0132

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  6 in total

1.  The diagnostic value of zinc transporter 8 autoantibody (ZnT8A) for type 1 diabetes in Chinese.

Authors:  Lin Yang; Shuoming Luo; Gan Huang; Jian Peng; Xia Li; Xiang Yan; Jian Lin; Janet M Wenzlau; Howard W Davidson; John C Hutton; Zhiguang Zhou
Journal:  Diabetes Metab Res Rev       Date:  2010-10       Impact factor: 4.876

2.  Predictive power of screening for antibodies against insulinoma-associated protein 2 beta (IA-2beta) and zinc transporter-8 to select first-degree relatives of type 1 diabetic patients with risk of rapid progression to clinical onset of the disease: implications for prevention trials.

Authors:  J De Grijse; M Asanghanwa; B Nouthe; N Albrecher; P Goubert; I Vermeulen; S Van Der Meeren; K Decochez; I Weets; B Keymeulen; V Lampasona; J Wenzlau; J C Hutton; D Pipeleers; F K Gorus
Journal:  Diabetologia       Date:  2009-11-29       Impact factor: 10.122

3.  IA-2 antibody isotypes and epitope specificity during the prediabetic process in children with HLA-conferred susceptibility to type I diabetes.

Authors:  S Hoppu; T Härkönen; M S Ronkainen; S Simell; A Hekkala; A Toivonen; J Ilonen; O Simell; M Knip
Journal:  Clin Exp Immunol       Date:  2006-04       Impact factor: 4.330

4.  Tetraspanin 7 autoantibodies predict progressive decline of beta cell function in individuals with LADA.

Authors:  Xiajie Shi; Gan Huang; Yanfei Wang; Zhenqi Liu; Chao Deng; Xia Li; Peilin Zheng; Zhiguang Zhou
Journal:  Diabetologia       Date:  2018-12-29       Impact factor: 10.122

5.  Novel prokaryotic expression of thioredoxin-fused insulinoma associated protein tyrosine phosphatase 2 (IA-2), its characterization and immunodiagnostic application.

Authors:  Luciano Lucas Guerra; Natalia Inés Faccinetti; Aldana Trabucchi; Bruno David Rovitto; Adriana Victoria Sabljic; Edgardo Poskus; Ruben Francisco Iacono; Silvina Noemí Valdez
Journal:  BMC Biotechnol       Date:  2016-11-24       Impact factor: 2.563

6.  The core cysteines, (C909) of islet antigen-2 and (C945) of islet antigen-2β, are crucial to autoantibody binding in type 1 diabetes.

Authors:  Karen T Elvers; Ivey Geoghegan; Debbie K Shoemark; Vito Lampasona; Polly J Bingley; Alistair J K Williams
Journal:  Diabetes       Date:  2012-09-10       Impact factor: 9.461

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.